Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis
- PMID: 6150753
- PMCID: PMC1236089
Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis
Abstract
Two dogs were diagnosed as malignant hyperthermia susceptible based on increased susceptibility (P less than 0.001) of biopsied muscle to caffeine-induced contracture. Erythrocytes from malignant hyperthermia and normal dogs were then examined for an antioxidant system deficiency. Values for serum muscle enzymes, reticulocytes and corpuscular hemoglobin were mildly elevated. Osmotic fragility was increased: hemolysis occurred at a NaCl concentration 10 mM higher than for normal dogs (P less than 0.001). A 35% glucose-6-phosphate dehydrogenase deficiency (P less than 0.001) with a 40% compensatory increase (P less than 0.01) in 6-phosphogluconate dehydrogenase activity was found. The membrane Ca2+-activated ATPase activity was abnormal: 100% increased with a 40% decreased Arrhenius activation energy (P less than 0.005) and increased thermostability. A 40% increased intracellular accumulation of total Ca2+ occurred in response to in vitro energy depletion in erythrocytes from one malignant hyperthermia dog (P less than 0.01). The multifactorial pattern of inheritance and the broad spectrum of malignant hyperthermia susceptibility are proposed to result from an antioxidant system deficit unmasking or aggravating an intrinsic muscle membrane anomaly. An individual from a family with a history of malignant hyperthermia or unexplained anesthetic death should be considered malignant hyperthermia susceptible if erythrocyte osmotic fragility is abnormal and there is a mild, unexplained elevation in serum creatine kinase.
Similar articles
-
Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.Can J Vet Res. 1990 Jan;54(1):83-92. Can J Vet Res. 1990. PMID: 2155050 Free PMC article. Review.
-
Canine stress syndrome/malignant hyperthermia susceptibility: calcium-homeostasis defect in muscle and lymphocytes.Res Vet Sci. 1990 Jan;48(1):124-8. Res Vet Sci. 1990. PMID: 2300706
-
Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility.Am J Vet Res. 1985 Jul;46(7):1451-6. Am J Vet Res. 1985. PMID: 4026025
-
Erythrocyte osmotic fragility, serum creatine kinase and its isoenzymes related to body weight in porcine malignant hyperthermia.J Comp Pathol. 1990 May;102(4):467-73. doi: 10.1016/s0021-9975(08)80167-3. J Comp Pathol. 1990. PMID: 2365858
-
Malignant hyperthermia. Preoperative assessment of risk factors.Br J Anaesth. 1988 Feb;60(3):317-9. doi: 10.1093/bja/60.3.317. Br J Anaesth. 1988. PMID: 3279992 Review. No abstract available.
Cited by
-
Measurement of the cytotoxic effects of different strains of Mycoplasma equigenitalium on the equine uterine tube using a calmodulin assay.Can J Vet Res. 1992 Oct;56(4):331-8. Can J Vet Res. 1992. PMID: 1477802 Free PMC article.
-
Malignant hyperthermia in dogs.Can Vet J. 1987 Jun;28(6):302-3. Can Vet J. 1987. PMID: 17422791 Free PMC article. No abstract available.
-
Isoflurane Induced Malignant Hyperthermia in a Patient with Glucose 6-Phosphate Dehydrogenase Deficiency and Growth Hormone Abuse.Case Rep Anesthesiol. 2020 Aug 6;2020:8888368. doi: 10.1155/2020/8888368. eCollection 2020. Case Rep Anesthesiol. 2020. PMID: 32832162 Free PMC article.
-
Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis.Can J Vet Res. 1990 Jan;54(1):83-92. Can J Vet Res. 1990. PMID: 2155050 Free PMC article. Review.
-
Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.Vet Res Commun. 1987;11(6):527-59. doi: 10.1007/BF00396370. Vet Res Commun. 1987. PMID: 2453969 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous